Preston C Sprenkle (Preston Sprenkle)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Benign Prostatic Hyperplasia

Ultrasound Guided

Machine Learning

Decision Making

Top Venues

Current urology reports

Current oncology reports

Exploration of targeted anti-tumor therapy

Case reports in urology

This page only lists publications with an associated author ORCID identifier.

Publications

Shayan Smani, Vinaik Sundaresan, Soum D Lokeshwar, Ankur U Choksi, Jeffrey Carbonella, Joseph Brito, Joseph Renzulli, Preston C Sprenkle, Michael S Leapman
Risk factors for Gleason score upgrade from prostate biopsy to radical prostatectomy. Exploration of targeted anti-tumor therapy 5 (4) (2024)
Gabriela M Diaz, Lindsey T Webb, Maximilian J Rabil, Soum D Lokeshwar, Ankur U Choksi, Michael S Leapman, Preston C Sprenkle
Risk Factors and Contemporary Management Options for Pain and Discomfort Experienced During a Prostate Biopsy. Current urology reports 25 (10) (2024)
Gabriela M Diaz, Lindsey T Webb, Maximilian J Rabil, Soum D Lokeshwar, Ankur U Choksi, Michael S Leapman, Preston C Sprenkle
Risk Factors and Contemporary Management Options for Pain and Discomfort Experienced During a Prostate Biopsy. Current urology reports (2024)
Soum D Lokeshwar, Jamil S Syed, Daniel Segal, Syed N Rahman, Preston C Sprenkle
Optimal Use of Tumor-Based Molecular Assays for Localized Prostate Cancer. Current oncology reports 24 (2) (2022)
Nathan Paulson, Tal Zeevi, Maria Papademetris, Michael S Leapman, John A Onofrey, Preston C Sprenkle, Peter A Humphrey, Lawrence H Staib, Angelique W Levi
Prediction of Adverse Pathology at Radical Prostatectomy in Grade Group 2 and 3 Prostate Biopsies Using Machine Learning. JCO clinical cancer informatics 6 (2022)
Kamyar Ghabili, Nathan Paulson, Jamil S Syed, Cayce B Nawaf, Ghazal Khajir, Darryl T Martin, John Onofrey, Michael S Leapman, Angelique Levi, Jeffrey C Weinreb, Peter A Humphrey, Preston C Sprenkle
Doubling of Decipher Biopsy Genomic Score Is Related to Disease Reclassification on Subsequent Surveillance Biopsy but Not Adverse Features on Radical Prostatectomy. Case reports in urology 2021 (2021)